Results 41 to 50 of about 235,111 (295)

Therapeutic Anticoagulation in Critically Ill Patients with Covid-19-Preliminary Report

medRxiv, 2021
Background Thrombosis may contribute to morbidity and mortality in Covid-19. We hypothesized that therapeutic anticoagulation would improve outcomes in critically ill patients with Covid-19.
E. Goligher, C. Bradbury, B. McVerry, P. Lawler, J. S. Berger, M. Gong, M. Carrier, H. R. Reynolds, A. Kumar, A. Turgeon, L. Kornblith, S. Kahn, J. Marshall, K. S. Kim, B. Houston, L. Derde, M. Cushman, T. Tritschler, D. Angus, L. C. Godoy, Z. McQuilten, B. Kirwan, M. Farkouh, M. Brooks, R. Lewis, A. Gordon, S. Berry, C. McArthur, M. Neal, J. S. Hochman, S. Webb, R. Zarychanski   +31 more
semanticscholar   +1 more source

Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2020
Importance Although current guidelines suggest the use of regional citrate anticoagulation (which involves the addition of a citrate solution to the blood before the filter of the extracorporeal dialysis circuit) as first-line treatment for continuous ...
A. Zarbock, M. Küllmar, D. Kindgen-Milles, C. Wempe, J. Gerss, T. Brandenburger, T. Dimski, B. Tyczynski, M. Jahn, Nils Mülling, M. Mehrländer, P. Rosenberger, G. Marx, T. Simon, U. Jaschinski, P. Deetjen, C. Putensen, J. Schewe, S. Kluge, D. Jarczak, T. Slowinski, M. Bodenstein, P. Meybohm, S. Wirtz, O. Moerer, A. Kortgen, P. Simon, S. Bagshaw, J. Kellum, M. Meersch   +29 more
semanticscholar   +1 more source

Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry

Thrombosis Journal, 2020
Background For the improvement of AF care, it is important to gain insight into current anticoagulation prescription practices and guideline adherence. This report focuses on the largest Dutch subset of AF-patients, derived from the GARFIELD-AF registry.
J. Seelig, F. W. A. Verheugt, M. E. W. Hemels, L. Illingworth, A. Lucassen, H. Adriaansen, M. C. M. Bongaerts, M. Pieterse, J. P. R. Herrman, P. Hoogslag, W. Hermans, B. E. Groenemeijer, L. V. A. Boersma, K. Pieper, H. ten Cate, on behalf of the GARFIELD-AF Investigators   +15 more
doaj   +1 more source

Does High-Dose Thromboprophylaxis Improve Outcomes in COVID-19 Patients? A Meta-analysis of Comparative Studies

TH Open, 2022
Background Thromboembolism remains a detrimental complication of novel coronavirus disease (COVID-19) despite the use of prophylactic doses of anticoagulation Objectives This study aimed to compare different thromboprophylaxis strategies in ...
Maha A. T. Elsebaie, Binav Baral, Mai Elsebaie, Trilok Shrivastava, Catherine Weir, Dennis Kumi, Noah W. Birch   +6 more
doaj   +1 more source

Fondaparinux Outpatient Use for Patients with a Heparin-Induced Thrombocytopenia History: A Case Report and Review

Pharmacy, 2016
The purpose of this article is to report a case of fondaparinux outpatient utilization for anticoagulation in a patient with a past medical history of heparin-induced thrombocytopenia (HIT) and discuss the options and need for future anticoagulation ...
Amy Christopher
doaj   +1 more source

Thrombosis and Bleeding in Extracorporeal Membrane Oxygenation (ECMO) Without Anticoagulation: A Systematic Review.

ASAIO journal (1992), 2020
Extracorporeal membrane oxygenation (ECMO) causes both thrombosis and bleeding. Major society guidelines recommend continuous, systemic anticoagulation to prevent thrombosis of the ECMO circuit, though this may be undesirable in those with active, or ...
S. Olson, Catherine R Murphree, David Zonies, Andrew D. Meyer, O. McCarty, T. Deloughery, J. Shatzel   +6 more
semanticscholar   +1 more source

Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality

Thrombosis and Haemostasis, 2020
Background Mortality in coronavirus disease of 2019 (COVID-19) is associated with increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has been proposed as therapy to decrease mortality, often adjusted for illness severity.
H. Billett, Morayma Reyes-Gil, James M Szymanski, K. Ikemura, Lindsay Stahl, Yungtai Lo, Shafia Rahman, Jesus D Gonzalez-Lugo, Margarita Kushnir, M. Barouqa, L. Golestaneh, E. Bellin   +11 more
semanticscholar   +1 more source

Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO

Critical Care, 2020
During extracorporeal membrane oxygenation (ECMO), a delicate balance is required to titrate systemic anticoagulation to prevent thrombotic complications within the circuit and prevent bleeding in the patient.
Meghan M. Chlebowski, Sirine A. Baltagi, M. Carlson, J. Levy, P. Spinella   +4 more
semanticscholar   +1 more source

Ischaemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke: the IAC study

Journal of Neurology Neurosurgery & Psychiatry, 2021
Background and purpose A subset of ischaemic stroke patients with atrial fibrillation (AF) have ischaemic stroke despite anticoagulation. We sought to determine the association between prestroke anticoagulant therapy and recurrent ischaemic events and ...
S. Yaghi, N. Henninger, James A. Giles, C. L. Leon Guerrero, Eva A. Mistry, Ava L. Liberman, Daniyal Asad, Angela Liu, Muhammad Nagy, Ashutosh Kaushal, Idrees Azher, B. M. Mac Grory, Hiba Fakhri, Kiersten Brown Espaillat, H. Pasupuleti, Heather Martin, Jose T Tan, Manivannan Veerasamy, Charles C. Esenwa, Natalie T. Cheng, Khadean Moncrieffe, Iman Moeini-naghani, Mithilesh Siddu, E. Scher, Tushar Trivedi, K. Furie, S. Keyrouz, A. Nouh, A. D. de Havenon, Muhib Khan, Eric E. Smith, M. Gurol   +31 more
semanticscholar   +1 more source

Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: A systematic review and meta-analysis

Frontiers in Pharmacology, 2023
Background: The benefits and risks of starting anticoagulation therapy, such as direct oral anticoagulations (DOACs) or warfarin, in atrial fibrillation (AF) patients with a history of intracranial hemorrhage (ICH) remain controversial.
Qiang Zhou, Xiang Liu, Xian Yang, Xiao-Hui Huang, Yan-Zi Wu, Ying-Ying Tao, Meng Wei   +6 more
doaj   +1 more source